Sorrento Therapeutics Inc (SRNE)

[1776club]

SOFUSA?
The first study completion is a P1 in January 2024. So is it a joke?
Pretty much so. A year late and millions short. The management team of Sorrento has squandered money but more importantly time. You can RS and get more money, but you can never get back time. The window of opportunity is just about shut on many studies.

Many big names plowing ahead: Major players in the microneedle drug delivery systems market are 3M, Zosano Pharma, Becton-Dickinson Technologies, Nanopass Technologies, Corium, Valeritas, Microdermics, TheraJect Inc, LTS Lohmann Therapie-Systeme AG, and BioSerenTach (BT). NOWHERE IS SORRENTO THERAPEUTICS CONSIDERED A MAJOR PLAYER IN THE FIELD.

https://www.businesswire.com/news/home/20220603005327/en/Microneedle-Drug-Delivery-Systems-Global-Market-Research-Report-2022---ResearchAndMarkets.com